12:00 AM
Dec 23, 2013
 |  BC Week In Review  |  Company News  |  Deals

Regeneron, Sanofi, American College of Cardiology deal

The American College of Cardiology (ACC) will use its PINNACLE (Practice Innovation and Clinical Excellence) registry research alliance to identify patients for Sanofi and Regeneron's Phase III ODYSSEY OUTCOMES trial. ACC noted that the companies do...

Read the full 157 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >